<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interleukin-6 (IL-6) has a dual role in modulating insulin sensitivity, with evidence for this cytokine as both an enhancer and inhibitor of insulin action </plain></SENT>
<SENT sid="1" pm="."><plain>We determined the effect of IL-6 exposure on <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in cultured myotubes established from people with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> IL-6 exposure increased <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthesis, <z:chebi fb="105" ids="17234">glucose</z:chebi> uptake, and signal transducer and activator of transcription 3 (STAT3) phosphorylation in cultured myotubes from <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant subjects </plain></SENT>
<SENT sid="3" pm="."><plain>However, in type 2 diabetic patients, IL-6 was without effect on <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism and STAT3 signaling, concomitant with increased suppressor of cytokine signaling 3 (SOCS3) expression </plain></SENT>
<SENT sid="4" pm="."><plain>IL-6 increased fatty acid oxidation in myotubes from type 2 diabetic and <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant subjects </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of IL-6, IL-6 receptor (IL-6R), or <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 130, as well as IL-6 secretion, was unaltered between cultured myotubes from <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant or type 2 diabetic subjects </plain></SENT>
<SENT sid="6" pm="."><plain>Circulating serum IL-6 concentration was unaltered between <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant and type 2 diabetic subjects </plain></SENT>
<SENT sid="7" pm="."><plain>In summary, skeletal muscle cells from type 2 diabetic patients display selective IL-6 resistance for <z:chebi fb="105" ids="17234">glucose</z:chebi> rather than <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, IL-6 appears to play a differential role in regulating metabolism in type 2 diabetic patients compared with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerant subjects </plain></SENT>
</text></document>